Search research articles
Contact Us
Filters
Showing results (231-240 of 516) with videos related to
Page
of 52
Sort By:
The Oncologist
|
April 24, 2022
Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma
Andrzej J Jakubowiak, Shaji Kumar, Rohan Medhekar, et al.
Blood Cancer Journal
|
February 10, 2021
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report
David L Murray, Noemi Puig, Sigurdur Kristinsson, et al.
Blood Cancer Journal
|
July 26, 2022
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
Marie-France Gagnon, Shulan Tian, Susan Geyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Neutralizing B-cell activating factor antibody improves survival and inhibits osteoclastogenesis in a severe combined immunodeficient human multiple myeloma model
Paola Neri, Shaji Kumar, Maria Teresa Fulciniti, et al.
Genes, Chromosomes & Cancer
|
June 14, 2021
Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma
Joanna C Dalland, James B Smadbeck, Neeraj Sharma, et al.
Medical Physics
|
August 19, 2022
Deep learning-based virtual noncalcium imaging in multiple myeloma using dual-energy CT
Hao Gong, Francis I Baffour, Katrina N Glazebrook, et al.
European Journal of Haematology
|
June 8, 2012
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation
Jonathan S Bleeker, Morie A Gertz, Patricia A Pellikka, et al.
British Journal of Haematology
|
October 12, 2013
Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis
Wei Ding, Tait D Shanafelt, Connie E Lesnick, et al.
Mayo Clinic Proceedings
|
June 9, 2012
Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population
Angela Dispenzieri, Jerry A Katzmann, Robert A Kyle, et al.
Blood
|
August 21, 2004
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
Noopur Raje, Shaji Kumar, Teru Hideshima, et al.
Page
of 52
Search research articles
Search
Showing results (231-240 of 516) with videos related to
Sort By:
Page
of 52
The Oncologist
|
April 24, 2022
Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma
Andrzej J Jakubowiak, Shaji Kumar, Rohan Medhekar, et al.
Blood Cancer Journal
|
February 10, 2021
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report
David L Murray, Noemi Puig, Sigurdur Kristinsson, et al.
Blood Cancer Journal
|
July 26, 2022
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
Marie-France Gagnon, Shulan Tian, Susan Geyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Neutralizing B-cell activating factor antibody improves survival and inhibits osteoclastogenesis in a severe combined immunodeficient human multiple myeloma model
Paola Neri, Shaji Kumar, Maria Teresa Fulciniti, et al.
Genes, Chromosomes & Cancer
|
June 14, 2021
Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma
Joanna C Dalland, James B Smadbeck, Neeraj Sharma, et al.
Medical Physics
|
August 19, 2022
Deep learning-based virtual noncalcium imaging in multiple myeloma using dual-energy CT
Hao Gong, Francis I Baffour, Katrina N Glazebrook, et al.
European Journal of Haematology
|
June 8, 2012
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation
Jonathan S Bleeker, Morie A Gertz, Patricia A Pellikka, et al.
British Journal of Haematology
|
October 12, 2013
Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis
Wei Ding, Tait D Shanafelt, Connie E Lesnick, et al.
Mayo Clinic Proceedings
|
June 9, 2012
Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population
Angela Dispenzieri, Jerry A Katzmann, Robert A Kyle, et al.
Blood
|
August 21, 2004
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
Noopur Raje, Shaji Kumar, Teru Hideshima, et al.
Page
of 52